Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2024-10-24
DOI
https://doi.org/10.3389/fonc.2024.1483660
Citations
3
Primary Topic
Cancer Mechanisms and Therapy
Type
article
Field-Weighted Citation Impact
1.27

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway

Qie Guo, Mengna Cui, Li Xiao, Long Xu
3 citations
Frontiers in Oncology
Cancer Mechanisms and Therapy
1.27
article

Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway

Qie Guo, Mengna Cui, Li Xiao, Long Xu
article en
3 citations

Abstract

No abstract available for this paper.
Frontiers in OncologyVol. 14
Qingdao University (CN), Affiliated Hospital of Qingdao University (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 19%
Cancer Mechanisms and Therapy
1.27
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.